Abbvie Inc ABBV:NYSE

Last Price$153.50NYSE Previous Close - Last Trade as of 7:00PM ET 5/13/22
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$153.60 (1)
Ask (Size)$154.25 (1)
Day Low / HighN/A - N/A
Volume4.0 K
  • Latest Stories
  • Commentary and Analysis
AbbVie Says Its Crohn's Disease Therapy Performed 'Significantly' Better Than Placebo in Phase 3 Maintenance Study
10:45AM ET 5/11/2022 MT Newswires

AbbVie (ABBV) said Wednesday its upadacitinib oral therapy for adults with moderate to severe Crohn's disease showed "significantly higher" endoscopic...

Research Alert: CFRA Keeps Buy Opinion On Shares Of Abbvie Inc.
1:35PM ET 5/02/2022 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

--Morgan Stanley Adjusts AbbVie's Price Target to $188 From $192, Reiterates Overweight Rating
8:39AM ET 5/02/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Wells Fargo Adjusts AbbVie's Price Target to $200 From $165, Reiterates Overweight Rating
8:30AM ET 5/02/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Hammered in Late-Week Rout
3:58PM ET 4/29/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 2.0% and the SPDR Health Care Select Sector ETF (XLV) down...

AbbVie Obtains FDA Approval for Rinvoq as Ankylosing Spondylitis Treatment
3:06PM ET 4/29/2022 MT Newswires

AbbVie (ABBV) said Friday that the Food and Drug Administration has approved the use of Rinvoq to treat adults with active ankylosing spondylitis, an...

AbbVie Shares Fall Sharply After Drugmaker Lowers 2022 Outlook
2:23PM ET 4/29/2022 MT Newswires

AbbVie's (ABBV) stock price dropped more than 8% in Friday afternoon trading after the drugmaker lowered its full-year profit outlook while its Q2 guidance...

Sector Update: Health Care Stocks Lower Friday but Outperforming Most Other Sectors
1:25PM ET 4/29/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 1.7% and the SPDR Health Care Select Sector ETF (XLV) down...

Sector Update: Health Care
1:17PM ET 4/29/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 1.7% while the SPDR Health Care Select Sector ETF (XLV) was...

AbbVie Cuts Full-Year Profit Outlook After First-Quarter Revenue Miss
1:03PM ET 4/29/2022 MT Newswires

AbbVie (ABBV) on Friday cut its full-year profit outlook and outlined second-quarter guidance that missed Wall Street's estimates after the drugmaker's...